Ultrasound score may sharpen risk prediction in rare lung disease
NCT ID NCT07266012
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looked at whether a special ultrasound score, called VExUS, can help doctors better understand risk in people with pulmonary arterial hypertension (PAH), a rare and serious lung condition. Researchers compared the VExUS score with standard tests like heart catheterization and blood work in 86 adults. The goal was to see if VExUS could improve how doctors predict complications and guide treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION PAH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Istanbul University-Cerrahpasa Institute of Cardiology
Istanbul, FATIH, 34098, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.